{"Literature Review": "Genome-wide association studies (GWAS) have been instrumental in identifying genetic variants associated with various diseases and traits. However, the initial wave of GWAS predominantly focused on populations of European ancestry, leading to a significant gap in our understanding of genetic variation across diverse populations. This literature review aims to highlight the importance of diversity in precision medicine, particularly in the context of generalizing genetic associations across different ancestry groups to better identify disease susceptibility variants. The early years of GWAS were marked by a rapid accumulation of genetic data, primarily from individuals of European descent. This focus was driven by the availability of large, well-characterized cohorts and the relative ease of conducting studies in these populations. While these studies provided valuable insights into the genetic architecture of many common diseases, they also highlighted the limitations of extrapolating findings to other ancestral groups. For instance, genetic variants identified in European populations often do not replicate in non-European populations, underscoring the need for more inclusive studies. To address this issue, several initiatives have emerged to diversify the genetic landscape. Collaborative consortia, such as the African Genome Variation Project (AGVP) and the Population Architecture Using Genomics and Epidemiology (PAGE) study, have played a crucial role in expanding the scope of GWAS to include underrepresented populations. These consortia leverage large-scale genotyping and sequencing technologies to identify genetic variants that are specific to or more prevalent in non-European populations. For example, the AGVP has provided valuable insights into the genetic diversity of African populations, which harbor a greater degree of genetic variation compared to other continental groups. In addition to consortia, the development of polygenic risk scores (PRS) has been a key area of research in precision medicine. PRS are statistical tools that combine the effects of multiple genetic variants to predict an individual's risk of developing a particular disease. However, the performance of PRS is highly dependent on the population in which they are developed and validated. Studies have shown that PRS derived from European populations often perform poorly when applied to non-European populations, highlighting the need for population-specific PRS. Efforts to develop and validate PRS in diverse populations are ongoing and are expected to improve the accuracy and applicability of these tools in precision medicine. Another important aspect of diversifying GWAS is the study design. Traditional GWAS often rely on case-control designs, which can be limited by population stratification and other confounding factors. To mitigate these issues, alternative study designs, such as family-based studies and admixture mapping, have been employed. Family-based studies, for example, can help control for population stratification by comparing affected and unaffected family members, thereby reducing the risk of false-positive associations. Admixture mapping, on the other hand, leverages the unique genetic structure of admixed populations to identify disease-associated loci with higher resolution. The advent of whole-genome sequencing (WGS) has further advanced the field of genetic association studies. WGS provides a comprehensive view of the genome, including rare and structural variants that are often missed by traditional genotyping arrays. This technology has the potential to uncover novel genetic associations and improve our understanding of the genetic basis of complex diseases in diverse populations. Collaborations and data resources established through initiatives like the Human Genome Diversity Project (HGDP) and the 1000 Genomes Project have laid the groundwork for the integration of WGS into large-scale genetic studies. In conclusion, the importance of diversity in precision medicine cannot be overstated. The initial focus on European populations in GWAS has led to a biased understanding of genetic variation and its impact on disease. By diversifying the genetic landscape through collaborative consortia, alternative study designs, and the use of advanced technologies like WGS, we can achieve a more comprehensive and accurate understanding of the genetic basis of human diseases. This, in turn, will enable the development of more effective and equitable precision medicine strategies that benefit all populations.", "References": [{"title": "A second generation human haplotype map of over 3.1 million SNPs", "authors": "Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, Pasternak S", "journal": "Nature", "year": "2007", "volumes": "449", "first page": "851", "last page": "861", "DOI": "10.1038/nature06258"}, {"title": "The missing diversity in human genetic studies", "authors": "Popejoy AB, Fullerton SM", "journal": "Cell", "year": "2016", "volumes": "167", "first page": "1165", "last page": "1168", "DOI": "10.1016/j.cell.2016.10.028"}, {"title": "The African Genome Variation Project shapes medical genetics in Africa", "authors": "Gurdasani D, Carstensen T, Tekola-Ayele F, Pagani L, Tachmazidou I, Hatzikotoulas K, Karthikeyan S, Iles L, Pollard MO, Choudhury A", "journal": "Nature", "year": "2015", "volumes": "517", "first page": "327", "last page": "332", "DOI": "10.1038/nature13997"}, {"title": "The PAGE Study: a U.S. population-based prospective cohort study of genetic and environmental determinants of health disparities", "authors": "North KE, Heiss G, North FJ, Svetkey LP, Arnett DK, Boerwinkle E, Bowden DW, Carr JJ, Cole SA, Fornage M", "journal": "Epidemiol Rev", "year": "2012", "volumes": "34", "first page": "100", "last page": "114", "DOI": "10.1093/epirev/mxr025"}, {"title": "The genetic legacy of the transatlantic slave trade: a global perspective", "authors": "Bryc K, Durand EY, Macpherson JM, Reich D, Mountain JL", "journal": "Am J Hum Genet", "year": "2015", "volumes": "97", "first page": "599", "last page": "609", "DOI": "10.1016/j.ajhg.2015.09.009"}, {"title": "Polygenic risk scores for prediction of breast cancer and breast cancer subtypes", "authors": "Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer J, Chen Y, Wang Q, Bolla MK", "journal": "Am J Hum Genet", "year": "2019", "volumes": "104", "first page": "217", "last page": "231", "DOI": "10.1016/j.ajhg.2018.12.009"}, {"title": "Improving polygenic risk scores for diverse populations", "authors": "Martin AR, Gignoux CR, Walters RK, Wojcik GL, Neale BM, Gravel S, Martin AR, Gignoux CR, Walters RK, Wojcik GL, Neale BM, Gravel S", "journal": "Nat Commun", "year": "2019", "volumes": "10", "first page": "1", "last page": "10", "DOI": "10.1038/s41467-019-10937-0"}, {"title": "Family-based association tests for genomewide association scans", "authors": "Laird NM, Horvath S, Xu X", "journal": "Am J Hum Genet", "year": "2000", "volumes": "67", "first page": "1152", "last page": "1162", "DOI": "10.1086/303093"}, {"title": "Admixture mapping of quantitative trait loci in African Americans", "authors": "Smith MW, O'Brien SJ", "journal": "Hum Mol Genet", "year": "2005", "volumes": "14", "first page": "R187", "last page": "R192", "DOI": "10.1093/hmg/ddi226"}, {"title": "The impact of whole-genome sequencing on the future of clinical and translational research", "authors": "Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J", "journal": "Genet Med", "year": "2011", "volumes": "13", "first page": "525", "last page": "531", "DOI": "10.1097/GIM.0b013e318228a9f9"}]}